| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 103,382 | 99,658 | 96,584 | 96,850 | | Cost of Revenue | 84,413 | 81,009 | 78,342 | 79,428 | | | Gross Profit | 18,969 | 18,649 | 18,242 | 17,422 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,179 | 9,805 | 9,671 | 9,838 | | Non Recurring | 468 |
-
|
-
|
-
| | Others | 1,486 | 1,502 | 1,489 | 1,327 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 6,836 | 7,342 | 7,082 | 6,257 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 73 | (550) | (183) | 425 | | Earnings Before Interest And Taxes | 6,909 | 6,792 | 6,899 | 6,682 | | Interest Expense | 943 | 752 | 724 | 1,436 | | Income Before Tax | 5,966 | 6,040 | 6,175 | 5,246 | | Income Tax Expense | 2,720 | 2,858 | 2,656 | 2,181 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,246 | 3,182 | 3,519 | 3,065 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,246 | 3,182 | 3,519 | 3,065 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $3,246 | $3,182 | $3,519 | $3,065 |
|
0.01% Nasdaq 0.00%
Income Statement
